topic
Good news about Cancer
Positive stories about Cancer, gathered from the newsrooms Rally reads. Every headline links back to the publisher who reported it.
6 stories.
SA’s CANCER STORY (Part 3): Amid many challenges there are also ‘major wins’ — the case of cervical cancer
South Africa’s HPV vaccination program is making progress in reducing cervical cancer rates, offering hope for future generations. This initiative is part of broader cancer advances, showing how targeted efforts can improve public health. The story highlights real progress in a challenging area.
Daily Maverick
Genetic testing program pioneered in Maritimes improving cancer care in Canada
A genetic testing program that helps rule out a stem-cell donor due to a genetic risk for developing leukemia was pioneered in the Maritimes, and is helping to improve cancer care.
Global News
PT Health Watch: How laboratory tests can help detect colorectal cancer early – Expert
Early detection of colorectal cancer is now possible through laboratory tests, even when symptoms are absent. This helps people identify the disease sooner, improving treatment outcomes. The news offers hope for better health management and early intervention.
Premium Times
Cal Ripken Jr.: My Most Important Streak Came After Baseball | Opinion
Cal Ripken Jr. turned his baseball fame into a force for good, founding a nonprofit to honor his late father by helping disadvantaged kids. His focus shifted from personal achievement to lifting others, creating lasting impact beyond the field. It’s a reminder of how public platforms can be used to build community and opportunity.
Newsweek
Palliative care and surgery encouraged for advanced cancer patients under new initiative
Cancer patient Gerald William Pereira (second from right) with (from left) Clinical Associate Professor Shirlynn Ho, Associate Psychologist Perlie Ng and Assistant Professor Jolene Wong.
The Straits Times
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
A new mRNA cancer vaccine has shown success in a Phase 3 trial for melanoma, helping patients avoid recurrence and spread. The treatment is personalized to target each patient’s unique cancer mutations, offering a promising new approach to fighting this deadly skin cancer.
Ars Technica
